Clinical Trials Browser

Phase 2 × Withdrawn × Flow Cytometry × Clear all

NCT00489710 2023-08-22

Talabostat in Treating Patients With Metastatic Kidney Cancer

Phase 2 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00845104 2015-03-06

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell